The Effects and Reproducibility of 10, 20, and 30% Velocity Loss Thresholds on Acute and Short-Term Fatigue and Recovery Responses.

ABSTRACT: Weakley, J, Johnston, RD, Cowley, N, Wood, T, Ramirez-Lopez, C, McMahon, E, and García-Ramos, A. The effects and reproducibility of 10, 20, and 30% velocity loss thresholds on acute and short-term fatigue and recovery responses. J Strength Cond Res 38(3): 465-473, 2024-This study aimed to establish the effects and reproducibility of implementing 10, 20, and 30% velocity loss thresholds (VLTs) during the free-weight barbell back squat on acute and short-term perceived soreness, neuromuscular fatigue, and physical performance. Using a repeated, counterbalanced, crossover design, 12 team-sport athletes completed on separate sessions 5 sets of the free-weight barbell back-squat until reaching VLTs of either 10, 20, or 30%. Outcomes were measured immediately postexercise and 24 hours after each session. To assess reproducibility, the same sessions were repeated after 4 weeks. Immediately postexercise, small differences in countermovement jump (CMJ) and 10-m sprint performance were observed between VLT conditions, whereas small to moderate differences in differential ratings of perceived exertion were reported (10% < 20% < 30%). At 24 hours, trivial differences in CMJ outcomes were found but small differences in 10-m sprint performance were detected between conditions (10% < 20% < 30%). In addition, at 24 hours, a single small difference in radial deformation using tensiomyography was found between 10 and 30% conditions, whereas large to very large differences in perceived soreness were reported between conditions (10% < 20% < 30%). Finally, the standard error of measurement of all outcome measures at 24 hours were of a similar magnitude to those reported in tightly controlled, short-term studies. Collectively, these findings demonstrate that VLTs help control the fatigue outcomes that occur as a response to resistance training and that they are reproducible. Therefore, for practitioners who wish to prescribe resistance training and be confident in the subsequent fatigue response, it is strongly advised that VLTs are implemented.

The Effect of Feedback on Resistance Training Performance and Adaptations: A Systematic Review and Meta-analysis.

BACKGROUND: Augmented feedback is often used during resistance training to enhance acute physical performance and has shown promise as a method of improving chronic physical adaptation. However, there are inconsistencies in the scientific literature regarding the magnitude of the acute and chronic responses to feedback and the optimal method with which it is provided. OBJECTIVE: This systematic review and meta-analysis aimed to (1) establish the evidence for the effects of feedback on acute resistance training performance and chronic training adaptations; (2) quantify the effects of feedback on acute kinematic outcomes and changes in physical adaptations; and (3) assess the effects of moderating factors on the influence of feedback during resistance training. METHODS: Twenty studies were included in this systematic review and meta-analysis. This review was performed using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Four databases were searched, and studies were included if they were peer-reviewed investigations, written in English, and involved the provision of feedback during or following dynamic resistance exercise. Furthermore, studies must have evaluated either acute training performance or chronic physical adaptations. Risk of bias was assessed using a modified Downs and Black assessment tool. Multilevel meta-analyses were performed to quantify the effects of feedback on acute and chronic training outcomes. RESULTS: Feedback enhanced acute kinetic and kinematic outputs, muscular endurance, motivation, competitiveness, and perceived effort, while greater improvements in speed, strength, jump performance, and technical competency were reported when feedback was provided chronically. Furthermore, greater frequencies of feedback (e.g., following every repetition) were found to be most beneficial for enhancing acute performance. Results demonstrated that feedback improves acute barbell velocities by approximately 8.4% (g = 0.63, 95% confidence interval [CI] 0.36-0.90). Moderator analysis revealed that both verbal (g = 0.47, 95% CI 0.22-0.71) and visual feedback (g = 1.11, 95% CI 0.61-1.61) were superior to no feedback, but visual feedback was superior to verbal feedback. For chronic outcomes, jump performance might have been positively influenced (g = 0.39, 95% CI - 0.20 to 0.99) and short sprint performance was likely enhanced (g = 0.47, 95% CI 0.10-0.84) to a greater extent when feedback is provided throughout a training cycle. CONCLUSIONS: Feedback during resistance training can lead to enhanced acute performance within a training session and greater chronic adaptations. Studies included in our analysis demonstrated a positive influence of feedback, with all outcomes showing superior results than when no feedback is provided. For practitioners, it is recommended that high-frequency, visual feedback is consistently provided to individuals when they complete resistance training, and this may be particularly useful during periods of low motivation or when greater competitiveness is beneficial. Alternatively, researchers must be aware of the ergogenic effects of feedback on acute and chronic responses and ensure that feedback is standardised when investigating resistance training.

The Criterion Validity and Between-Day Reliability of the Perch for Measuring Barbell Velocity During Commonly Used Resistance Training Exercises.

ABSTRACT: Weakley, J, Munteanu, G, Cowley, N, Johnston, R, Morrison, M, Gardiner, C, Pérez-Castilla, A, and García-Ramos, A. The criterion validity and between-day reliability of the Perch for measuring barbell velocity during commonly used resistance training exercises. J Strength Cond Res 37(4): 787-792, 2023-This study aimed to assess the criterion validity and between-day reliability (accounting for technological and biological variability) of mean and peak concentric velocity from the Perch measurement system. On 2 testing occasions, 16 subjects completed repetitions at 20, 40, 60, 80, 90, and 100% of 1-repetition maximum in the free-weight barbell back squat and bench press. To assess criterion validity, values from the Perch and a 3-dimensional motion capture system (criterion) were compared. Technological variability was assessed by determining whether the differences between the Perch and criterion for each load were comparable for both testing sessions, whereas between-day reliability with both technological and biological variability was calculated from Perch values across days. Generalized estimating equations were used to calculate R2 and root mean square error, whereas Bland-Altman plots assessed magnitude of difference between measures. To support monitoring of athletes over time, standard error of measurement and minimum detectable changes (MDC) were calculated. There was excellent agreement between the Perch and criterion device, with mean velocity in both exercises demonstrating a mean bias ranging from -0.01 to 0.01 m·s -1 . For peak velocity, Perch underestimated velocity compared with the criterion ranging from -0.08 to -0.12 m·s -1 for the back squat and -0.01 to -0.02 m·s -1 for the bench press. Technological variability between-days were all less than the MDC. These findings demonstrate that the Perch provides valid and reliable mean and peak concentric velocity outputs across a range of velocities. Therefore, practitioners can confidently implement this device for the monitoring and prescription of resistance training.

Comparing accuracy of bedside ultrasound examination with physical examination for detection of pleural effusion.

BACKGROUND: In detecting pleural effusion, bedside ultrasound (US) has been shown to be more accurate than auscultation. However, US has not been previously compared to the comprehensive physical examination. This study seeks to compare the accuracy of physical examination with bedside US in detecting pleural effusion. METHODS: This study included a convenience sample of 34 medical inpatients from Calgary, Canada and Spokane, USA, with chest imaging performed within 24 h of recruitment. Imaging results served as the reference standard for pleural effusion. All patients underwent a comprehensive lung physical examination and a bedside US examination by two researchers blinded to the imaging results. RESULTS: Physical examination was less accurate than US (sensitivity of 44.0% [95% confidence interval (CI) 30.0-58.8%], specificity 88.9% (95% CI 65.3-98.6%), positive likelihood (LR) 3.96 (95% CI 1.03-15.18), negative LR 0.63 (95% CI 0.47-0.85) for physical examination; sensitivity 98% (95% CI 89.4-100%), specificity 94.4% (95% CI 72.7-99.9%), positive LR 17.6 (95% CI 2.6-118.6), negative LR 0.02 (95% CI 0.00-0.15) for US). The percentage of examinations rated with a confidence level of 4 or higher (out of 5) was higher for US (85% of the seated US examination and 94% of the supine US examination, compared to 35% of the PE, P < 0.001), and took less time to perform (P < 0.0001). CONCLUSIONS: US examination for pleural effusion was more accurate than the physical examination, conferred higher confidence, and required less time to complete.

Magnitude and modifiers of the weekend effect in hospital admissions: a systematic review and meta-analysis.

OBJECTIVE: To examine the magnitude of the weekend effect, defined as differences in patient outcomes between weekend and weekday hospital admissions, and factors influencing it. DESIGN: A systematic review incorporating Bayesian meta-analyses and meta-regression. DATA SOURCES: We searched seven databases including MEDLINE and EMBASE from January 2000 to April 2015, and updated the MEDLINE search up to November 2017. Eligibility criteria: primary research studies published in peer-reviewed journals of unselected admissions (not focusing on specific conditions) investigating the weekend effect on mortality, adverse events, length of hospital stay (LoS) or patient satisfaction. RESULTS: For the systematic review, we included 68 studies (70 articles) covering over 640 million admissions. Of these, two-thirds were conducted in the UK (n=24) or USA (n=22). The pooled odds ratio (OR) for weekend mortality effect across admission types was 1.16 (95% credible interval 1.10 to 1.23). The weekend effect appeared greater for elective (1.70, 1.08 to 2.52) than emergency (1.11, 1.06 to 1.16) or maternity (1.06, 0.89 to 1.29) admissions. Further examination of the literature shows that these estimates are influenced by methodological, clinical and service factors: at weekends, fewer patients are admitted to hospital, those who are admitted are more severely ill and there are differences in care pathways before and after admission. Evidence regarding the weekend effect on adverse events and LoS is weak and inconsistent, and that on patient satisfaction is sparse. The overall quality of evidence for inferring weekend/weekday difference in hospital care quality from the observed weekend effect was rated as 'very low' based on the Grading of Recommendations, Assessment, Development and Evaluations framework. CONCLUSIONS: The weekend effect is unlikely to have a single cause, or to be a reliable indicator of care quality at weekends. Further work should focus on underlying mechanisms and examine care processes in both hospital and community. PROSPERO REGISTRATION NUMBER: CRD42016036487.

Safety and Efficacy of Antiviral Therapy for Prevention of Cytomegalovirus Reactivation in Immunocompetent Critically Ill Patients: A Randomized Clinical Trial.

Importance: Latent cytomegalovirus (CMV) infection is present in more than half the adult population, and a viral reactivation (ie, when the virus becomes measurable in body fluids such as blood) can occur in up to one-third of these individuals during episodes of critical illness. Objective: To determine whether antiviral therapy is safe and effective for preventing CMV reactivation in a general population of critically ill patients. Design, Setting, and Participants: A single-center, open-label, randomized, controlled clinical trial recruited 124 CMV-seropositive patients undergoing mechanical ventilation for at least 24 hours in the intensive care unit between January 1, 2012, and January 31, 2014. The mean baseline Acute Physiology and Chronic Health Evaluation II score of all patients was 17.6. Interventions: Patients were randomized to receive anti-CMV prophylaxis with valacyclovir hydrochloride (n = 34) or low-dose valganciclovir hydrochloride (n = 46) for up to 28 days to suppress viral reactivation, or to a control group with no intervention (n = 44). Main Outcomes and Measures: Time to first CMV reactivation in blood within the 28-day follow-up period following initiation of the study drug. Results: Among the 124 patients in the study (46 women and 78 men; mean [SD] age, 56.9 [16.9] years), viral reactivation in the blood occurred in 12 patients in the control group, compared with 1 patient in the valganciclovir group and 2 patients in the valacyclovir group (combined treatment groups vs control: hazard ratio, 0.14; 95% CI 0.04-0.50). Although this trial was not powered to assess clinical end points, the valacyclovir arm was halted prematurely because of higher mortality; 14 of 34 patients (41.2%) had died by 28 days, compared with 5 of 37 (13.5%) patients in the control arm at the point of the decision to halt this arm. Other safety end points showed similar outcomes between groups. Conclusions and Relevance: Antiviral prophylaxis with valacyclovir or low-dose valganciclovir suppresses CMV reactivation in patients with critical illness. However, given the higher mortality, a large-scale trial would be needed to determine the clinical efficacy and safety of CMV suppression. Trial Registration: clinicaltrials.gov Identifier: NCT01503918.

Assessment of the performance of the Marsh model in effect site mode for target controlled infusion of propofol during the maintenance phase of general anaesthesia in an unselected population of neurosurgical patients.

BACKGROUND: Propofol target-controlled infusion (TCI) in effect site mode has become popular since it became commercially available. OBJECTIVE: We have performed a study to assess the pharmacokinetic performance of the Marsh model in effect site mode in an unselected group of patients during neurosurgery during the maintenance phase of anaesthesia. DESIGN: Fifty American Society of Anesthesiologists (ASA) physical status classes 1 to 3 adults underwent elective neurosurgery receiving propofol TCI using the Marsh model in effect site mode. Propofol dose titration and level of patient monitoring was determined by the attending anaesthesiologist. Arterial blood was sampled at regular intervals during the maintenance phase of anaesthesia and measured plasma propofol concentrations were compared with those estimated using TCI. SETTING: Large tertiary referral centre in Birmingham, UK, with a specialist neuroanaesthesia service. PATIENTS: Fifty ASA status I to III adult patients undergoing elective neurosurgery. MAIN OUTCOME MEASURES: Performance of Marsh model as assessed by median performance error (bias) and median absolute performance error (imprecision). RESULTS: Performance of the Marsh model showed a positive bias (median performance error) of 27.6%, and imprecision (median absolute performance error) of 29.4%. Analysis of pooled data demonstrated greatest bias in the early phase (15 to 30 min) of anaesthesia (mean prediction error of 51.6%). Analysis of covariates demonstrated that obesity (BMI >30 kg m(-2)) contributed around half of the bias detected (mean prediction error 47 vs. 23%, P < 0.001). Patients with advanced age and significant comorbidity (ASA physical status class >2) actually demonstrated significantly lower prediction errors. CONCLUSION: Pharmacokinetic analysis suggests that the performance of the Marsh model in effect site mode is poor in this broad patient population. The greatest bias demonstrated occurred in the early maintenance phase of anaesthesia. Of the covariates analysed, obesity contributed most significantly to an increased bias. Despite overall poor performance of the Marsh model, attending anaesthesiologists modified targeted propofol concentrations only 0.3 times per hour on average, using remifentanil dose modification nine times more frequently, with good surgical conditions in all patients.